Innovent Biologics, Inc. (HKG:1801)
Hong Kong · Delayed Price · Currency is HKD 78.80
+2.55 (3.34%)
At close: Jan 2, 2026
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 131.21 billion as of January 2, 2026. Its market cap has increased by 111.92% in one year.
Market Cap
131.21B
Enterprise Value
124.46B
Revenue
12.52B
Ranking
n/a
PE Ratio
103.14
Stock Price
78.80
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 131.21B, an increase of 607.76%. That is a compound annual growth rate of 31.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 131.21B | 118.84% |
| Dec 31, 2024 | 59.96B | -13.32% |
| Dec 29, 2023 | 69.17B | 34.57% |
| Dec 30, 2022 | 51.40B | -27.14% |
| Dec 31, 2021 | 70.55B | -38.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 262.40B |
| Hansoh Pharmaceutical Group Company | 218.43B |
| JD Health International | 178.11B |
| WuXi Biologics | 129.79B |
| Sino Biopharmaceutical | 110.48B |
| Akeso | 104.09B |
| CSPC Pharmaceutical Group | 96.38B |
| Sichuan Kelun-Biotech Biopharmaceutical | 91.46B |